loadpatents
Patent applications and USPTO patent grants for Warne; Nicholas W..The latest application filed is for "human antibodies that bind human il-12 and methods for producing".
Patent | Date |
---|---|
Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same Grant 9,035,030 - Salfeld , et al. May 19, 2 | 2015-05-19 |
Methods of treatment using human antibodies that bind IL-12 Grant 8,865,174 - Salfeld , et al. October 21, 2 | 2014-10-21 |
Human antibodies that bind human interleukin-12 Grant 8,765,918 - Salfeld , et al. July 1, 2 | 2014-07-01 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20120308514 - Salfeld; Jochen ;   et al. | 2012-12-06 |
Anti A beta antibody formulation Grant 8,318,164 - Warne , et al. November 27, 2 | 2012-11-27 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20120244168 - Salfeld; Jochen ;   et al. | 2012-09-27 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20120213792 - Salfeld; Jochen ;   et al. | 2012-08-23 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20120201831 - Salfeld; Jochen G. ;   et al. | 2012-08-09 |
Hydroxyethyl Starch-containing Polypeptide Compositions App 20120134958 - WARNE; Nicholas W. ;   et al. | 2012-05-31 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20110123544 - Salfeld; Jochen G. ;   et al. | 2011-05-26 |
Hydroxyethyl Starch-Containing Polypeptide Compositions App 20110091415 - Warne; Nicholas W. ;   et al. | 2011-04-21 |
Methods for inhibiting the activity of the P40 subunit of human IL-12 Grant 7,883,704 - Salfeld , et al. February 8, 2 | 2011-02-08 |
Protein Formulations with Reduced Viscosity and Uses Thereof App 20110027292 - WARNE; NICHOLAS W. ;   et al. | 2011-02-03 |
Protein formulations with reduced viscosity and uses thereof Grant 7,758,860 - Warne , et al. July 20, 2 | 2010-07-20 |
Stable Antibody Compositions And Methods Of Stabilizing Same App 20100172862 - Correia; Ivan R. ;   et al. | 2010-07-08 |
Anti A Beta Antibody Formulation App 20100166752 - Warne; Nicholas W. ;   et al. | 2010-07-01 |
Hemophilia Treatment by Inhalation of Coagulation Factors App 20100124536 - Schaub; Robert G. ;   et al. | 2010-05-20 |
Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same App 20100062058 - Warne; Nicholas W. ;   et al. | 2010-03-11 |
Anti A.beta. antibody formulation Grant 7,635,473 - Warne , et al. December 22, 2 | 2009-12-22 |
Human antibodies that bind human IL-12 and methods for producing App 20090311241 - Salfeld; Jochen G. ;   et al. | 2009-12-17 |
Human Antibodies That Bind Human Il-12 And Methods For Producing App 20090269302 - SALFELD; Jochen ;   et al. | 2009-10-29 |
Hydroxyethyl Starch-containing Polypeptide Compositions App 20090185996 - Warne; Nicholas W. ;   et al. | 2009-07-23 |
Human Antibodies That Bind Human IL-12 And Methods For Producing App 20090175857 - Salfeld; Jochen ;   et al. | 2009-07-09 |
Human antibodies that bind human IL-12 Grant 7,504,485 - Salfeld , et al. March 17, 2 | 2009-03-17 |
Hydroxyethyl starch-containing polypeptide compositions Grant 7,449,444 - Warne , et al. November 11, 2 | 2008-11-11 |
Use Of Sucrose To Suppress Mannitol-Induced Protein Aggregation App 20080200656 - Sek; David C. ;   et al. | 2008-08-21 |
Protein Formulations With Reduced Viscosity and Uses Thereof App 20080160014 - Warne; Nicholas W. ;   et al. | 2008-07-03 |
Protein formulations with reduced viscosity and uses thereof Grant 7,390,786 - Warne , et al. June 24, 2 | 2008-06-24 |
Methods for reducing or preventing liquid-liquid phase separation in high concentration protein solutions App 20080070230 - Li; Li ;   et al. | 2008-03-20 |
Human antibodies that bind human IL-12 and methods for producing App 20080063634 - Salfeld; Jochen G. ;   et al. | 2008-03-13 |
Prediction of relative polypeptide solubility by polyethylene glycol precipitation App 20080003686 - Li; Li ;   et al. | 2008-01-03 |
Protein formulations with reduced viscosity and uses thereof App 20070172479 - Warne; Nicholas W. ;   et al. | 2007-07-26 |
Stabilized liquid polypeptide formulations App 20060210557 - Luisi; Donna ;   et al. | 2006-09-21 |
Anti a beta antibody formulation App 20060193850 - Warne; Nicholas W. ;   et al. | 2006-08-31 |
Formulations for IL-11 App 20060159656 - Warne; Nicholas W. ;   et al. | 2006-07-20 |
Formulations for IL-11 Grant 7,033,992 - Warne , et al. April 25, 2 | 2006-04-25 |
Hydroxyethyl starch-containing polypeptide compositions App 20060079450 - Warne; Nicholas W. ;   et al. | 2006-04-13 |
Hydroxyethyl starch--containing polypeptide compositions Grant 6,982,080 - Warne , et al. January 3, 2 | 2006-01-03 |
Human antibodies that bind human IL-12 and methods for producing Grant 6,914,128 - Salfeld , et al. July 5, 2 | 2005-07-05 |
Hemophilia treatment by inhalation of coagulation factors App 20050008580 - Gong, David K. ;   et al. | 2005-01-13 |
Human antibodies that bind human IL-12 and methods for producing App 20050004354 - Salfeld, Jochen ;   et al. | 2005-01-06 |
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same App 20040126358 - Warne, Nicholas W. ;   et al. | 2004-07-01 |
Formulations for IL-11 App 20040057927 - Warne, Nicholas W. ;   et al. | 2004-03-25 |
Hydroxyethyl starch - containing polypeptide compositions App 20040029776 - Warne, Nicholas W. ;   et al. | 2004-02-12 |
Topical formulations for delivery of interleukin-11 App 20030147849 - Warne, Nicholas W. ;   et al. | 2003-08-07 |
Method of treating inflammatory bowel disease using a topical formulation of IL-11 Grant 6,540,993 - Warne , et al. April 1, 2 | 2003-04-01 |
Formulations for IL-11 Grant 6,270,757 - Warne August 7, 2 | 2001-08-07 |
Formulations for IL-12 Grant 5,744,132 - Warne , et al. April 28, 1 | 1998-04-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.